These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4092830)

  • 21. Inhibitory effect of lithium on neuroleptic and serotonin receptors in rat brain.
    Tanimoto K; Maeda K; Terada T
    Brain Res; 1983 Apr; 265(1):148-51. PubMed ID: 6850317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
    Berzétei IP; Bagdy E; Hardy M; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin-S2 and dopamine-D2 receptors are the same size in membranes.
    Brann MR
    Biochem Biophys Res Commun; 1985 Dec; 133(3):1181-6. PubMed ID: 2935151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein nature of D2 dopamine receptors.
    Grigoriadis DE; Niznik HB; Jarvie KR; Seeman P
    FEBS Lett; 1988 Jan; 227(2):220-4. PubMed ID: 2962888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubilisation of high-affinity dopamine receptors.
    Gorissen H; Laduron P
    Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
    [No Abstract]   [Full Text] [Related]  

  • 28. Solubilization of serotonin S2-receptors from human brain.
    Schotte A; Maloteaux JM; Laduron PM
    Eur J Pharmacol; 1984 May; 100(3-4):329-33. PubMed ID: 6734724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride.
    Redouane K; Sokoloff P; Schwartz JC; Hamdi P; Mann A; Wermuth CG; Roy J; Morgat JL
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1086-92. PubMed ID: 3161508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the serotonin-S2 receptor ligand binding site by photoaffinity labelling with 7-azido-8-[125I]ketanserin ([125I]AZIK).
    Wouters W; Van Dun J; Laduron PM
    FEBS Lett; 1987 Mar; 213(2):359-64. PubMed ID: 3556587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubilization of multiple binding sites for the dopamine receptor from calf striatal membranes.
    Clement-Cormier YC; Meyerson LR; McIsaac A
    Biochem Pharmacol; 1980 Jul; 29(14):2009-16. PubMed ID: 7406913
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS; Dakshinamurti K
    J Neurosci Res; 1985; 14(2):263-70. PubMed ID: 4046074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling.
    Amlaiky N; Caron MG
    J Neurochem; 1986 Jul; 47(1):196-204. PubMed ID: 2940337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of D2 dopamine receptors in dopamine-resistant prolactin-secreting rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Lafond J; Beauregard G; Potier M; Collu R
    J Neurochem; 1987 Nov; 49(5):1644-50. PubMed ID: 2959753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortex.
    Lemos JR; Barberis C; Tassin JP; Bockaert J
    Brain Res; 1984 Dec; 323(1):47-54. PubMed ID: 6098335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilization of the neuroleptic binding receptor from rat striatum.
    Lew JY; Fong JC; Goldstein M
    Eur J Pharmacol; 1981 Jul; 72(4):403-5. PubMed ID: 7274334
    [No Abstract]   [Full Text] [Related]  

  • 37. Photoaffinity labeling of dopamine D1 receptors.
    Niznik HB; Jarvie KR; Bzowej NH; Seeman P; Garlick RK; Miller JJ; Baindur N; Neumeyer JL
    Biochemistry; 1988 Oct; 27(20):7594-9. PubMed ID: 3207691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine receptor: isolation, purification, and regulation.
    Clement-Cormier YC
    Adv Biochem Psychopharmacol; 1980; 21():159-67. PubMed ID: 7376969
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimisation of conditions for solubilisation of the bovine dopamine D2 receptor.
    Hooper RJ
    J Neurochem; 1986 Oct; 47(4):1080-5. PubMed ID: 2943871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB
    Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.